Different suppressive effects of fucoidan and lentinan on IL-8 mRNA expression in in Vitro gut inflammation

Bioscience, Biotechnology and Biochemistry

Volumn 73, Issue 10, 2009, Pages 2324-2325

  Mizuno, Masashi ^a   Nishitani, Yosuke ^a   Hashimoto, Takashi ^a   Kanazawa, Kazuki ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Fucoidan; Interleukin 8; Intestinal bowel diseases; Lentinan; Tumor necrosis factor

Indexed keywords

ANTI-INFLAMMATORY EFFECTS; CACO-2 CELLS; CO-CULTURE SYSTEM; FUCOIDAN; FUCOIDANS; IN-VITRO; INTERLEUKIN-8; INTESTINAL BOWEL DISEASES; LENTINAN; LIPOPOLYSACCHARIDES; MRNA EXPRESSION; TUMOR NECROSIS FACTORS;

CELL CULTURE; GLYCOPROTEINS; POLYSACCHARIDES; TUMORS;

MACROPHAGES;

ANTIINFLAMMATORY AGENT; FUCOIDIN; INTERLEUKIN 8; LENTINAN; MESSENGER RNA; POLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; CELL STRAIN CACO 2; DRUG EFFECT; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLAMMATION; MACROPHAGE; METABOLISM;

ANTI-INFLAMMATORY AGENTS; CACO-2 CELLS; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-8; LENTINAN; MACROPHAGES; POLYSACCHARIDES; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350446611     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.90326     Document Type: Article

References (19)

1. Mizuno M, Morimoto M, Minato K, and Tsuchida H, Biosci. Biotechnol. Biochem., 62, 434-437 (1998).
2. Mizuno M, Shiomi Y, Minato K, Kawakami S, Ashida H, and Tsuchida H, Immunopharmacology, 46, 113-121 (2000).
3. Morimoto T, Takagi M, and Mizuno M, Int. J. Med. Mushrooms, 10, 15-24 (2008).
4. Chihara G, Hamuro J, Maeda YY, Arai Y, and Fukuoka F, Cancer Res., 30, 2776-2781 (1970).
5. Maruyama H, Tamauchi H, Iizuka M, and Nakano T, Planta Med., 72, 1415-1417 (2006).
6. Ponce MA, Pujol CA, Damonte EB, Flores ML, and Stortz CA, Carbohydr. Res., 338, 153-165 (2003).
7. Sakai S, Akiyama H, Harikai N, Toyoda H, Toida T, Maitani T, and Imanari T, Immunol. Lett., 84, 211-216 (2002).
8. Hamuro J, Röiinghoff M, and Wagner H, Cancer Res., 38, 3080-3085 (1978).
9. Nanba H and Kuroda H, Chem. Pharm. Bull., 35, 2459-2464 (1987).
10. Kerékgyártó C, Virág L, Tankó L, Chihara G, and Fachet J, Int. J. Immunopharmacol., 18, 347-353 (1996).
11. Fruehauf JP, Bonnard GD, and Herberman RB, Immunophar-macology, 5, 65-74 (1982).
12. Cumashi A, Ushakova NA, Preobrazhenskaya ME, D'Incecco A, Piccoli A, Totani L, Tinari N, Morozevich GE, Berman AE, Bilan MI, Usov AI, Ustyuzhanina NE, Grachev AA, Sanderson CJ, Kelly M, Rabinovich GA, Iacobelli S, and Nifantiev NE, Glycobiology, 17, 541-552 (2007).
13. Hsu HY, Chiu SL, Wen MH, Chen KY, and Hua KF, J. Biol. Chem., 276, 28719-28730 (2001).
14. Choi EM, Kim AJ, Kim YO, and Hwang JK, J. Med. Food, 8, 446-453 (2005).
15. Kim MH and Joo HG, Immunol. Lett., 115, 138-143 (2008).
16. Tanoue T, Nishitani Y, Kanazawa K, Hashimoto T, and Mizuno M, Biochem. Biophys. Res. Commun., 374, 565-569 (2008).
17. Mizuno M, Minato K, and Tsuchida H, Biochem. Mol. Biol. Int., 39, 679-685 (1996).
18. Mizuno M, Nishitani Y, Tanoue T, Matoba Y, Ojima T, Hashimoto T, and Kanazawa K, Biosci. Biotechnol. Biochem., 73, 335-338 (2009).
19. Rice PJ, Adams EL, Ozment-Skelton T, Gonzalez AJ, Goldman MP, Lockhart BE, Barker LA, Breuel KF, Deponti WK, Kalbfleisch JH, Ensley HE, Brown GD, Gordon S, and Williams DL, J. Pharmacol. Exp. Ther., 314, 1079-1086 (2005).